Age at onset of amyotrophic lateral sclerosis in China

Acta Neurologica Scandinavica

Volumn 129, Issue 3, 2014, Pages 163-167

  Liu, M S ^a   Cui, L Y ^a   Fan, D S ^b   Liu, Mingsheng ^c   Cui, Li Ying ^c   Fan, Dong Seng ^c   Lu, Jiahong ^c   Zhou, Dong ^c   Zhang, Cheng ^c   Yan, Chuan Zhu ^c   Li, Cun Jiang ^c   Pu, Chuan Qiang ^c   Ding, Xing Sheng ^c   Liu, Ya Ling ^c   Li, Xiao Guang ^c   Chen, Yan ^c   Zhang, Jun ^c   Shang, Hui Fang ^c   Yao, Xiao Li ^c   Ding, Yan ^c   Huang, Xu Sheng ^c   Niu, Qi ^c   Wang, Li Ping ^c   more..

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c NONE

Author keywords

Amyotrophic lateral sclerosis; Clinical features; Epidemiology; Risk factor

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHINA; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPED COUNTRY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURES; EPIDEMIOLOGY; RISK FACTOR;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84893656939     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12157     Document Type: Article

References (30)

1. Schiffer D, Briguolio F, Chio A, Leoni M, Rosso MG. A study of prognostic factors in motor neuron disease. Adv Exp Med Biol 1987;209:255-63.
2. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993;16:27-32.
3. Preux PM, Couratier P, Boutros-Toni F et al. Survival prediction in sporadic amyotrophic lateral sclerosis: age and clinical form at onset are independent risk factors. Neuroepidemiology 1996;15:153-60.
4. Atsuta N, Watanabe H, Ito M et al. Age at onset influence on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2009;276:163-9.
5. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986;36:511-7.
6. Huisman MH, de Jong SW, van Doormaal PT et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry 2011;82:1165-70.
7. Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1, 153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci 2008;272:60-70.
8. Fang DF, Zhang SS, Guo XY et al. Clinical and genetic features of patients with sporadic amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler 2009;10:350-4.
9. Liu XX, Zhang J, Zheng JY et al. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis. Muscle Nerve 2009;39:304-9.
10. Korner S, Kollewe K, Fahlbusch M et al. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve 2011;43:636-42.
11. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-19.
12. Kim WK, Liu X, Sandner J et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009;73:1686-92.
13. Kihira T, Yoshida S, Okamoto K et al. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci 2008;268:95-101.
14. Gil J, Vazquez MC, Ketzoian C et al. Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population. Amyotroph Lateral Scler 2009;10:355-60.
15. Joensen P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand 2012;126(1):62-6.
16. Abhinav K, Stanton B, Johnston C et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology 2007;29:44-8.
17. López-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand 1988;77:1-5.
18. O'Toole O, Traynor BJ, Brennan P et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008;79:30-2.
19. De Carvalho M, Dengler R, Eisen A et al. Electrodiagnostic criteria for the diagnosis of ALS. Clin Neurophys 2008;119:497-503.
20. Swingler RJ, Fraser H, Warlow CP. Motor neuron disease and polio in Scotland. J Neurol Neurosurg Psychiatry 1992;55:1116-20.
21. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-9.
22. Logroscino G, Beghi E, Zoccolella S et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 2005;76:1094-8.
23. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy. Evidence for a uniform frequency in Western countries. Neurology 2001;56:239-44.
24. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008;79:6-11.
25. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996;47:571-3.
26. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55:1106-15.
27. Forbes RB, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 2004;33:131-4.
28. Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003;22:217-28.
29. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington state. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156-63.
30. Giagheddu M, Puggioni G, Tacconi P et al. Amyotrophic lateral sclerosis in Sardinia (Italy): epidemiologic features from 1957 to 2000. Acta Neurol Scand 2013;127:251-9.